Veterinary Medicine Information website

Dexafort suspension injectable

Authorised
  • DEXAMETHASONE 21-PHENYLPROPIONATE
  • Dexamethasone sodium phosphate
Download as PDF

Product identification

Medicine name:
Dexafort suspension injectable
Active substance:
  • DEXAMETHASONE 21-PHENYLPROPIONATE
  • Dexamethasone sodium phosphate
Target species:
  • Dog
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • DEXAMETHASONE 21-PHENYLPROPIONATE
    2.67
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dexamethasone sodium phosphate
    1.32
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        63
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Available in:
  • Luxembourg
Package description:
  • 1 x 50 ml vial (glass) with suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • V 817/06/01/0853
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 11/08/2023
Download